- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DMK Pharmaceuticals Corp (0A4X)
DMK Pharmaceuticals Corp stock price live, this page displays OTC DMKPQ stock exchange data. View the DMKPQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DMK Pharmaceuticals Corp real time stock price chart below.
What Is the DMK Pharmaceuticals Corp Stock Price Today?
The DMK Pharmaceuticals Corp stock price today is 0.01.
What Is the Stock Symbol for DMK Pharmaceuticals Corp?
The stock symbol for DMK Pharmaceuticals Corp is ""DMKPQ.""
What Stock Exchange Does DMK Pharmaceuticals Corp Trade On?
DMK Pharmaceuticals Corp is listed and trades on the OTC Markets stock exchange.
Is DMK Pharmaceuticals Corp a Good Stock to Buy?
Determining whether DMK Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DMKPQ quote. (ISIN: US00547W3079)
What Is the DMK Pharmaceuticals Corp Stock Price Today?
The DMK Pharmaceuticals Corp stock price today is 0.01.
What Is the Stock Symbol for DMK Pharmaceuticals Corp?
The stock symbol for DMK Pharmaceuticals Corp is ""DMKPQ.""
What Stock Exchange Does DMK Pharmaceuticals Corp Trade On?
DMK Pharmaceuticals Corp is listed and trades on the OTC Markets stock exchange.
Is DMK Pharmaceuticals Corp a Good Stock to Buy?
Determining whether DMK Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DMKPQ quote. (ISIN: US00547W3079)
0.01
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a DMK Pharmaceuticals Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.01
0.01
52 wk Range
0.01
0.01
0A4X Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
1/3
Fair Value
An estimate of a DMK Pharmaceuticals Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.010.01
52 wk Range
0.010.01
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0A4X Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a DMK Pharmaceuticals Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
DMK Pharmaceuticals Corp Company Profile
DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company’s lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California. On February 2, 2024, DMK Pharmaceuticals Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 28, 2024.
Compare 0A4X to Peers and Sector
Metrics to compare | 0A4X | Peers Peers - average of corresponding metrics from companies closely matching 0A4X: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0A4XPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 3.3x | |
Upside (Analyst Target) | 0.0% | 0.0% | 43.5% | |
Fair Value Upside | Unlock | 0.0% | 6.9% | Unlock |
Earnings
Latest Release
Nov 14, 2023
EPS / Forecast
-0.25 / --
Revenue / Forecast
9.06K / --
FAQ
What Stock Exchange Does DMK Pharmaceuticals Corp Trade On?
DMK Pharmaceuticals Corp is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for DMK Pharmaceuticals Corp?
The stock symbol for DMK Pharmaceuticals Corp is "0A4X."
What Is the DMK Pharmaceuticals Corp Market Cap?
As of today, DMK Pharmaceuticals Corp market cap is 10.09.
What Is DMK Pharmaceuticals Corp's Earnings Per Share (TTM)?
The DMK Pharmaceuticals Corp EPS (TTM) is -6.09.
From a Technical Analysis Perspective, Is 0A4X a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has DMK Pharmaceuticals Corp Stock Split?
DMK Pharmaceuticals Corp has split 0 times.
How Many Employees Does DMK Pharmaceuticals Corp Have?
DMK Pharmaceuticals Corp has 12 employees.
What is the current trading status of DMK Pharmaceuticals Corp (0A4X)?
As of 07 Aug 2025, DMK Pharmaceuticals Corp (0A4X) is trading at a price of 0.01, with a previous close of 0.00. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 0.01.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.